Intelligence Platform

Patents

Browse 912 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9636515

Method of repairing age and disease immune dysfunction and cellular senescence with lympho

Advanced Neuroregenerative Therapies, LLC. · Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9629877

Human application of engineered chimeric antigen receptor (CAR) T-cells

The Board of Regents of the University of Texas System · Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9629897

Methods of producing and using regulatory B-cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9624509

Modulation of stem cells using zinc finger proteins

Sangamo Biosciences, Inc. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9624472

Production of insulin producing cells

Regents of the University of Minnesota · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9623040

Immunomodulation by controlling expression levels of microRNAs in dendritic cells

The Regents of the University of California · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9616090

Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

Sangamo Biosciences, Inc. · Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9617512

Derivation of embryonic stem cells and embryo-derived cells

Astellas Institute for Regenerative Medicine · Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9611456

Progenitor cells from wharton'S jelly of human umbilical cord

Tissue Regeneration Therapeutics Inc. · Granted Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9593162

Internalizing human monoclonal antibodies targeting prostate cancer cells in situ

The Regents of the University of California · Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9592304

Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9566250

Artificial tissue constructs comprising alveolar cells and methods for using the same

SANOFI PASTEUR VAXDESIGN CORPORATION · Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9566352

Methods and compositions for inhibiting viral entry into cells

Sangamo Biosciences, Inc. · Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9567564

Progenitor cells from Wharton's jelly of human umbilical cord

Tissue Regeneration Therapeutics Inc. · Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9567402

Internalizing human monoclonal antibodies targeting prostate and other cancer cells

The Regents of the University of California · Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9562237

Reduction of TGF beta signaling in myeloid cells in the treatment of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9550974

Derivation of embryonic stem cells

Astellas Institute for Regenerative Medicine · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9549954

Method and composition for inducing human pluripotent stem cells

The Regents of the University of California · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9545422

Methods of inducing photosensitivity by targeting channelrhodopsin-2 and halorhodopsin to

The Regents of the University of California · Granted Tue Jan 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9545451

Anti-PRLR antibodies and methods for killing PRLR-expressing cells

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9539341

Methods and compositions for targeting adipose cells in mammals

The Board of Regents of the University of Texas System · Granted Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9526747

Use of multipotent adult stem cells in treatment of myocardial infarction and congestive h

Regents of the University of Minnesota · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9506041

Delivery of packaged RNA to mammalian cells

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9498544

Genetically modified human umbilical cord perivascular cells for prophylaxis against or tr

Tissue Regeneration Therapeutics Inc. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted